Back to top
more

Encompass Health (EHC)

(Real Time Quote from BATS)

$103.02 USD

103.02
234,355

-0.51 (-0.49%)

Updated Nov 8, 2024 02:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (51 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Brookdale Senior (BKD) Shares Jump 18.7% Since Q2 Earnings Beat

by Zacks Equity Research

Brookdale Senior (BKD) expects adjusted EBITDA to be within the $73-$78 million range in the third quarter.

Zacks.com featured highlights Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle

by Zacks Equity Research

Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle have been highlighted in this Screen of The Week article.

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

by Zacks Equity Research

The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.

Urmimala Biswas headshot

5 Lucrative Value Picks Based on Discounted PEG

by Urmimala Biswas

Here are five stocks that match our screening criteria, BABA, EHC, TAP, F and ALB.

Encompass Health's (EHC) Q2 Earnings Beat, '23 EPS View Raised

by Zacks Equity Research

Encompass Health's (EHC) Q2 results reflect a growing patient base and improved net patient revenue per discharge. Management anticipates 2023 adjusted EPS within $3.31-$3.53, up from the earlier view of $2.94-$3.23.

Shaun Pruitt headshot

Here's Why Investors Should Buy These 2 Medical Stocks After Earnings

by Shaun Pruitt

Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex Pharmaceuticals (VRTX) stock.

Compared to Estimates, Encompass Health (EHC) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Encompass Health (EHC) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of 28.38% and 2.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Acadia Healthcare's (ACHC) New Facility Boosts Pennsylvania Reach

by Zacks Equity Research

Acadia Healthcare (ACHC) commences operations at one of the two hospitals, which form a part of its JV with Geisinger. The company is committed to offer enhanced behavioral health services in Pennsylvania.

Here's Why Investors Should Add Encompass Health (EHC) to Portfolio

by Zacks Equity Research

Encompass Health (EHC) remains well-poised for growth on the back of solid demand for effective inpatient rehabilitation services, joint ventures and solid cash reserves.

Is DaVita (DVA) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cigna (CI) to Add Three Biosimilars to NPF, Enable Cost Savings

by Zacks Equity Research

Cigna (CI) plans to integrate three cost-effective biosimilars within NPF in a bid to offer varied treatment options for Americans and solidify its pharmacy business.

Here's Why Encompass Health (EHC) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Encompass Health (EHC) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Encompass Health's (EHC) 158th Hospital Opens in Maryland

by Zacks Equity Research

The Rehabilitation Hospital of Bowie is Encompass Health's (EHC) second location in the state of Maryland.

DaVita HealthCare (DVA) Down 1.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why Investors Should Hold Encompass Health (EHC) Now

by Zacks Equity Research

Encompass Health (EHC) remains well-poised for growth, attributable to expanding patient admissions, robust expansion endeavors and strong cash-generating abilities.

Encompass Health (EHC) to Build New Hospital in Concordville

by Zacks Equity Research

The new inpatient rehabilitation unit is likely to be the 10th hospital of Encompass Health (EHC) in Pennsylvania.

Why Encompass Health (EHC) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Encompass Health's (EHC) Q1 Earnings Beat, '23 EPS View Up

by Zacks Equity Research

Encompass Health's (EHC) Q1 results reflect improved patient volumes and higher discharge growth. Management estimates 2023 adjusted EPS within $2.94-$3.23, up from the earlier view of $2.87-$3.16.

Encompass Health (EHC) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of 25.71% and 1.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare (ADUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Investors Undervaluing Encompass Health (EHC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Earnings Preview: Encompass Health (EHC) Q1 Earnings Expected to Decline

by Zacks Equity Research

Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EHC vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

EHC vs. CHE: Which Stock Is the Better Value Option?